Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Bolt Biotherapeutics (BOLT) EPS (Basic) (2020 - 2025)

Historic EPS (Basic) for Bolt Biotherapeutics (BOLT) over the last 6 years, with Q3 2025 value amounting to -$3.72.

  • Bolt Biotherapeutics' EPS (Basic) rose 5308.95% to -$3.72 in Q3 2025 from the same period last year, while for Sep 2025 it was $14.61, marking a year-over-year increase of 17378.79%. This contributed to the annual value of -$1.78 for FY2024, which is 298.18% up from last year.
  • Per Bolt Biotherapeutics' latest filing, its EPS (Basic) stood at -$3.72 for Q3 2025, which was up 5308.95% from -$4.46 recorded in Q2 2025.
  • In the past 5 years, Bolt Biotherapeutics' EPS (Basic) registered a high of -$0.28 during Q1 2024, and its lowest value of -$11.12 during Q2 2024.
  • In the last 5 years, Bolt Biotherapeutics' EPS (Basic) had a median value of -$0.6 in 2022 and averaged -$1.91.
  • As far as peak fluctuations go, Bolt Biotherapeutics' EPS (Basic) soared by 9503.4% in 2021, and later tumbled by 221666.67% in 2024.
  • Bolt Biotherapeutics' EPS (Basic) (Quarter) stood at -$0.73 in 2021, then rose by 27.4% to -$0.53 in 2022, then increased by 11.32% to -$0.47 in 2023, then rose by 11.2% to -$0.42 in 2024, then crashed by 791.34% to -$3.72 in 2025.
  • Its last three reported values are -$3.72 in Q3 2025, -$4.46 for Q2 2025, and -$0.29 during Q1 2025.